Health Catalyst, Inc. — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-03-01

Reporting Person: Orenstein Daniel H. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-01	Common Stock	F	733.00	$48.5968	Disposed	82313.00	Direct
2021-03-01	Common Stock	F	23.00	$49.628	Disposed	82290.00	Direct
2021-03-02	Common Stock	S	1744.00	$47.5153	Disposed	80546.00	Direct

Footnotes

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: Represents the weighted average sale price of the shares sold ranging from $48.15 to $49.06 per share, inclusive.

F3: Represents the weighted average sale price of the shares sold ranging from $49.17 to $49.93 per share, inclusive.

F4: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.

F5: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.21 to $48.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2), (3), and (5).